These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17450965)

  • 1. Does stimulant medication decrease the lower extremity response times of children with and without attention-deficit/hyperactivity disorder?
    Brasić JR
    Percept Mot Skills; 2007 Feb; 104(1):67-8. PubMed ID: 17450965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of stimulant medication on lower extremity response time of boys with attention deficit hyperactivity disorder.
    Pedersen SJ; Surburg PR
    Percept Mot Skills; 2005 Oct; 101(2):401-7. PubMed ID: 16383070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
    Cohen-Zion M; Ancoli-Israel S
    Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of the effects of stimulant medication on response inhibition: a comparison between children with and without attention deficit hyperactivity disorder.
    Brackenridge R; McKenzie K; Murray GC; Quigley A
    Res Dev Disabil; 2011; 32(6):2797-804. PubMed ID: 21700419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to Brasić (2007): psychomotor study of children with ADHD.
    Pedersen SJ
    Percept Mot Skills; 2008 Jun; 106(3):891-2. PubMed ID: 18712212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M; Akhondzadeh S
    Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian motor activity affected by stimulant medication in children with attention-deficit/hyperactivity disorder.
    Ironside S; Davidson F; Corkum P
    J Sleep Res; 2010 Dec; 19(4):546-51. PubMed ID: 20629940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant medications.
    Greenhill LL; Halperin JM; Abikoff H
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):503-12. PubMed ID: 10230181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
    Hammerness PG; Perrin JM; Shelley-Abrahamson R; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):978-90. PubMed ID: 21961773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.